Literature DB >> 28569344

Radiofrequency treatment induces fibroblast growth factor 2 expression and subsequently promotes neocollagenesis and neoangiogenesis in the skin tissue.

Patrícia Froes Meyer1, Patrícia de Oliveira1, Flávia K B A Silva1, Ana C S da Costa1, Caline R A Pereira1, Sebastian Casenave2, Rodrigo Marcel Valentim Silva3, Luis Gonzaga Araújo-Neto1, Sebastião David Santos-Filho4, Eric Aizamaque1, Hennes Gentil Araújo1, Mario Bernardo-Filho4, Maria Goretti Freire Carvalho5, Ciro Dantas Soares6,7,8.   

Abstract

Radiofrequency (RF) treatment appears to be involved in production of new collagen fibrils and the improvement of existing collagen structures; however, the molecular bases of the effect of non-invasive RF on the skin tissue have not been fully elucidated. This study reports the effects of RF associated or not with hydrolyzed collagen (HC) in the skin tissue. Wistar rats were randomly divided into four groups, according to the treatment received: control group (G1, n = 5), no treatment; subjects in group G2 (n = 5) were treated with HC; and capacitive RF was applied to the back of each subject in G3 (n = 5) and RF associated with HC in G4 (n = 5). Biopsies were taken 30 days after treatment and then were histologically processed and studied for inflammatory cell counting, collagen content, and morphometry. In addition, FGF2, CD105, and COX-2 expression was assessed by immunohistochemical staining. The most relevant changes were the increase in cellularity and accumulation of intercellular substance in RF-treated animals (G3 and G4). The greatest dermis thickness rate was observed in G4, followed by G3 and G2 (p < 0.05). RF-treated skins (G3 and G4) exhibited a significant overexpression of FGF2 (p < 0.0001) and increased microvessel density (p < 0.0001) in comparison with G1 and G2. Moreover, the amount of COX-2 was significantly higher (p < 0.0001) in dermis of RF-treated areas compared to G1 and G2, and demonstrated differences in G3 (RF) compared to G4 (RF + HC) (p < 0.0001). Our results suggests that RF treatment associated or not with HC induces FGF2 overexpression, promotes neoangiogenesis and modulates the COX-2 expression, subsequently promotes neocollagenesis, and increased thickness rate of dermis.

Entities:  

Keywords:  Angiogenesis; Cyclooxygenase 2; Endoglin; Fibroblastic growth factor 2; Hydrolyzed collagen; Neocollagenesis; Radiofrequency

Mesh:

Substances:

Year:  2017        PMID: 28569344     DOI: 10.1007/s10103-017-2238-2

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  35 in total

Review 1.  ["Skin rejuvenation" by non-ablative laser and light systems. Literature research and overview].

Authors:  H Grema; C Raulin; B Greve
Journal:  Hautarzt       Date:  2002-06       Impact factor: 0.751

Review 2.  Update on non-ablative light therapy for rejuvenation: a review.

Authors:  Neil S Sadick
Journal:  Lasers Surg Med       Date:  2003       Impact factor: 4.025

3.  Non-ablative skin tightening with radiofrequency in Asian skin.

Authors:  Nobuharu Kushikata; Kei Negishi; Yukiko Tezuka; Kaori Takeuchi; Shingo Wakamatsu
Journal:  Lasers Surg Med       Date:  2005-02       Impact factor: 4.025

4.  Ultrastructural evaluation of multiple pass low energy versus single pass high energy radio-frequency treatment.

Authors:  David Kist; A Jay Burns; Roth Sanner; Jeff Counters; Brian Zelickson
Journal:  Lasers Surg Med       Date:  2006-02       Impact factor: 4.025

Review 5.  Ablative CO2 lasers for skin tightening: traditional versus fractional.

Authors:  Arisa E Ortiz; Mitchel P Goldman; Richard E Fitzpatrick
Journal:  Dermatol Surg       Date:  2014-12       Impact factor: 3.398

6.  Effects of multi-polar radiofrequency and pulsed electromagnetic field treatment in Koreans: case series and survey study.

Authors:  Young Bok Lee; Young Sun Eun; Ji Hae Lee; Min Seok Cheon; Baik Kee Cho; Hyun Jeong Park
Journal:  J Dermatolog Treat       Date:  2012-09-19       Impact factor: 3.359

7.  Molecular mechanisms and in vivo mouse models of skin aging associated with dermal matrix alterations.

Authors:  Kyung-A Hwang; Bo-Rim Yi; Kyung-Chul Choi
Journal:  Lab Anim Res       Date:  2011-03-25

8.  Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.

Authors:  David C Crowley; Francis C Lau; Prachi Sharma; Malkanthi Evans; Najla Guthrie; Manashi Bagchi; Debasis Bagchi; Dipak K Dey; Siba P Raychaudhuri
Journal:  Int J Med Sci       Date:  2009-10-09       Impact factor: 3.738

9.  Daily consumption of the collagen supplement Pure Gold Collagen® reduces visible signs of aging.

Authors:  Maryam Borumand; Sara Sibilla
Journal:  Clin Interv Aging       Date:  2014-10-13       Impact factor: 4.458

10.  Ingestion of BioCell Collagen(®), a novel hydrolyzed chicken sternal cartilage extract; enhanced blood microcirculation and reduced facial aging signs.

Authors:  Stephen R Schwartz; Joosang Park
Journal:  Clin Interv Aging       Date:  2012-07-27       Impact factor: 4.458

View more
  3 in total

1.  Histological examination of skin tissue in the porcine animal model after simultaneous and consecutive application of monopolar radiofrequency and targeted pressure energy.

Authors:  Brian M Kinney; Dian Kanakov; Penka Yonkova
Journal:  J Cosmet Dermatol       Date:  2019-12-03       Impact factor: 2.696

2.  Radiofrequency Irradiation Mitigated UV-B-Induced Skin Pigmentation by Increasing Lymphangiogenesis.

Authors:  Hyoung Moon Kim; Seyeon Oh; Kyung-A Byun; Jin Young Yang; Hye Jin Sun; Donghwan Kang; Kuk Hui Son; Kyunghee Byun
Journal:  Molecules       Date:  2022-01-11       Impact factor: 4.411

Review 3.  Effects of Non-Invasive Radiofrequency Diathermy in Pelvic Floor Disorders: A Systematic Review.

Authors:  María Dolores González-Gutiérrez; Álvaro López-Garrido; Irene Cortés-Pérez; Esteban Obrero-Gaitán; Felipe León-Morillas; Alfonso Javier Ibáñez-Vera
Journal:  Medicina (Kaunas)       Date:  2022-03-17       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.